Tofacitinib for Refractory Immune-Related Colitis from PD-1 Therapy

N Engl J Med. 2020 Jun 11;382(24):2374-2375. doi: 10.1056/NEJMc2002527.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Colitis*
  • Colitis, Ulcerative*
  • Humans
  • Piperidines
  • Programmed Cell Death 1 Receptor
  • Pyrimidines
  • Pyrroles

Substances

  • Piperidines
  • Programmed Cell Death 1 Receptor
  • Pyrimidines
  • Pyrroles
  • tofacitinib